14 results on '"Pagano, Maria Teresa"'
Search Results
2. The Role of Sex Differences in Bone Health and Healing.
- Author
-
Ortona, Elena, Pagano, Maria Teresa, Capossela, Lavinia, and Malorni, Walter
- Subjects
- *
BONE health , *FRACTURE healing , *HEALING , *GENDER inequality , *CELL cycle , *BONE regeneration - Abstract
Simple Summary: Fracture healing is a complex process that includes a framework of events triggered by tissue injury. Clinical experience with bone healing revealed a series of cellular and biochemical actors encompassing the repair mechanisms in human beings. However, the different responses of individuals in this scenario are still a matter of debate. We analyze herein in some detail the disparity between men and women in this process. Based on the literature, we suggest that different mechanisms could underlie bone healing in men and women and that the role of estrogen could be pivotal in delayed fracture repair observed in women. Fracture healing is a long-term and complex process influenced by a huge variety of factors. Among these, there is a sex/gender disparity. Based on significant differences observed in the outcome of bone healing in males and females, in the present review, we report the main findings, hypotheses and pitfalls that could lead to these differences. In particular, the role of sex hormones and inflammation has been reported to have a role in the observed less efficient bone healing in females in comparison with that observed in males. In addition, estrogen-induced cellular processes such as autophagic cell cycle impairment and molecular signals suppressing cell cycle progression seem also to play a role in female fracture healing delay. In conclusion, it seems conceivable that a complex framework of events could contribute to the female bias in bone healing, and we suggest that a reappraisal of the compelling factors could contribute to the mitigation of sex/gender disparity and improve bone healing outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Human Monocyte-Derived Dendritic Cells Are the Pharmacological Target of the Immunosuppressant Flavonoid Silibinin.
- Author
-
Pagano, Maria Teresa, Fecchi, Katia, Pierdominici, Marina, Ortona, Elena, and Peruzzu, Daniela
- Subjects
- *
FLAVONOIDS , *SILIBININ , *T cells , *MONOCYTES , *AUTOIMMUNE diseases , *THERAPEUTICS , *ANTIGEN presenting cells - Abstract
Silibinin, a natural polyphenolic flavonoid, is known to possess anti-inflammatory, anticancer, antioxidant, and immunomodulatory properties. However, the effects of Silibinin on the maturation and immunostimulatory functions of human dendritic cells (DC) remain to be elucidated. In this study, we have attempted to ascertain whether Silibinin influences the maturation, cytokine production, and antigen-presenting capacity of human monocyte-derived DC. We show that Silibinin significantly suppresses the upregulation of costimulatory and MHC molecules in LPS-stimulated mature DC and inhibits lipopolysaccharide (LPS)-induced interleukin (IL)-12, IL-23, and TNF-α production. Furthermore, Silibinin impairs the proliferation response of the allogenic memory CD4 T lymphocytes elicited by LPS-matured DC and their Th1/Th17 profile. These findings demonstrate that Silibinin displays immunosuppressive activity by inhibiting the maturation and activation of human DC and support its potential application of adjuvant therapy in the treatment of autoimmune diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Anti-Inflammatory Effects of 1,25(OH)2D/Calcitriol in T Cell Immunity: Does Sex Make a Difference?
- Author
-
Peruzzu, Daniela, Dupuis, Maria Luisa, Pierdominici, Marina, Fecchi, Katia, Gagliardi, Maria Cristina, Ortona, Elena, and Pagano, Maria Teresa
- Subjects
CALCITRIOL ,VITAMIN D receptors ,VITAMIN D ,IMMUNITY ,T cells ,RHEUMATOID arthritis - Abstract
Hypovitaminosis D is involved in various inflammatory, infectious and autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. Moreover, the active form of vitamin D, calcitriol, has been shown to modulate the immune response, playing an anti-inflammatory effect. However little is known about the mechanisms underlying this anti-inflammatory effect and the potential sex differences of calcitriol immune regulation. Hence, the aim of this study was to investigate whether calcitriol could act differently in modulating T cell immunity of age-matched male and female healthy donors. We analyzed the effects of calcitriol in T lymphocytes from healthy women and men on the expression levels of the vitamin D receptor (VDR) and pro- and anti-inflammatory cytokine production. We showed that a treatment with calcitriol induced a significant increase in the VDR expression levels of activated T lymphocytes from male and female healthy subjects. Moreover, we found that calcitriol significantly reduced the expression level of pro-inflammatory cytokines IL-17, INF-γ and TNF-α in the T lymphocytes of both sexes. Notably, we observed that calcitriol induced a significant increase in the expression level of anti-inflammatory cytokine IL-10 only in the T lymphocytes from female healthy donors. In conclusion, our study provides new insights regarding the sex-specific anti-inflammatory role of calcitriol in T cell immunity. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
5. Predicting respiratory failure in patients infected by SARS-CoV-2 by admission sex-specific biomarkers.
- Author
-
Pagano, Maria Teresa, Peruzzu, Daniela, Busani, Luca, Pierdominici, Marina, Ruggieri, Anna, Antinori, Andrea, D'Offizi, Gianpiero, Petrosillo, Nicola, Palmieri, Fabrizio, Piselli, Pierluca, Cicalini, Stefania, Notari, Stefania, Nicastri, Emanuele, Agrati, Chiara, Ippolito, Giuseppe, Vaia, Francesco, Gagliardi, Maria Cristina, Capobianchi, Maria Rosaria, Ortona, Elena, and INMI-ISS COVID-19 team
- Subjects
- *
LYMPHOCYTE count , *RESPIRATORY insufficiency , *SARS-CoV-2 , *ADULT respiratory distress syndrome , *COVID-19 , *BIOMARKERS , *SEX factors in disease - Abstract
Background: Several biomarkers have been identified to predict the outcome of COVID-19 severity, but few data are available regarding sex differences in their predictive role. Aim of this study was to identify sex-specific biomarkers of severity and progression of acute respiratory distress syndrome (ARDS) in COVID-19. Methods: Plasma levels of sex hormones (testosterone and 17β-estradiol), sex-hormone dependent circulating molecules (ACE2 and Angiotensin1-7) and other known biomarkers for COVID-19 severity were measured in male and female COVID-19 patients at admission to hospital. The association of plasma biomarker levels with ARDS severity at admission and with the occurrence of respiratory deterioration during hospitalization was analysed in aggregated and sex disaggregated form. Results: Our data show that some biomarkers could be predictive both for males and female patients and others only for one sex. Angiotensin1-7 plasma levels and neutrophil count predicted the outcome of ARDS only in females, whereas testosterone plasma levels and lymphocytes counts only in males. Conclusions: Sex is a biological variable affecting the choice of the correct biomarker that might predict worsening of COVID-19 to severe respiratory failure. The definition of sex specific biomarkers can be useful to alert patients to be safely discharged versus those who need respiratory monitoring. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
6. Vitamin D and Sex Differences in COVID-19.
- Author
-
Pagano, Maria Teresa, Peruzzu, Daniela, Ruggieri, Anna, Ortona, Elena, and Gagliardi, Maria Cristina
- Subjects
VITAMIN D ,COVID-19 ,VITAMIN D receptors ,CALCIUM supplements ,ESTROGEN ,COVID-19 pandemic - Published
- 2020
- Full Text
- View/download PDF
7. The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis.
- Author
-
Dupuis, Maria Luisa, Conti, Fabrizio, Maselli, Angela, Pagano, Maria Teresa, Ruggieri, Anna, Anticoli, Simona, Fragale, Alessandra, Gabriele, Lucia, Gagliardi, Maria Cristina, Sanchez, Massimo, Ceccarelli, Fulvia, Alessandri, Cristiano, Valesini, Guido, Ortona, Elena, and Pierdominici, Marina
- Subjects
ESTROGEN receptors ,SILIBININ ,RHEUMATOID arthritis - Abstract
Estrogens, in particular 17β-estradiol (E2), have a strong influence on the immune system and also affect pathological conditions such as autoimmune diseases. The biological effects of E2 are mediated by two intracellular receptors, i.e., estrogen receptor (ER)α and ERβ, which function as ligand-activated nuclear transcription factors producing genomic effects. Immune cells express both ERα and ERβ that play a complex role in modulating inflammation. Phytoestrogens display estrogen-like effects. Among them, silibinin, the major active constituent of silymarin extracted by the milk thistle (Silybum marianum), has been suggested to have an ERβ selective binding. Silibinin is known to have anti-inflammatory, hepatoprotective, and anticarcinogenic effects; however, the role of silibinin in modulating human immune responses and its impact on autoimmunity remains unclear. Aim of this study was to dissect the ability of the ERβ natural ligand silibinin to modulate T cell immunity, taking into account possible differences between females and males, and to define its possible role as therapeutic tool in immune-mediated diseases. To this purpose, female and age-matched male healthy subjects and patients with active rheumatoid arthritis (RA) were recruited. We evaluated the ability of silibinin to modulate ERβ expression in T lymphocytes and its effects on T cell functions (i.e., apoptosis, proliferation, and cytokine production). We also analyzed whether silibinin was able to modulate the expression of microRNA-155 (miR-155), which strongly contributes to the pathogenesis of RA driving aberrant activation of the immune system. We demonstrated that silibinin upregulated ERβ expression, induced apoptosis, inhibited proliferation, and reduced expression of the pro-inflammatory cytokines IL-17 and TNF-α, through ERβ binding, in T lymphocytes from female and male healthy donors. We obtained similar results in T lymphocytes from patients with active RA in term of apoptosis, proliferation, and cytokine production. In addition, we found that silibinin acted as an epigenetic modifier, down-modulating the expression of miR-155. In conclusion, our data demonstrated an immunosuppressive role of silibinin, supporting its application in the treatment of autoimmune diseases as drug, but also as dietary nutritional supplement, opening new perspective in the field of autoimmune disease management. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
8. The Sex-Related Interplay between TME and Cancer: On the Critical Role of Estrogen, MicroRNAs and Autophagy.
- Author
-
Matarrese, Paola, Mattia, Gianfranco, Pagano, Maria Teresa, Pontecorvi, Giada, Ortona, Elena, Malorni, Walter, and Carè, Alessandra
- Subjects
AUTOPHAGY ,ESTROGEN ,MICRORNA ,SEX hormones ,TUMORS - Abstract
Simple Summary: Autophagy is a complex cell process that allow the cell to survive in unfavorable conditions, e.g., in the lack of nutritional elements coming from the environment. Here we focused on the role played by autophagy in the crosstalk between the microenvironment surrounding the tumor and cancer cells. This environment is in fact known as pivotal in determining the growth or the inhibition of a tumor. Cancer progression and response to therapy significantly differ between women and men and the microenvironment, in particular sex hormones and microRNAs, appears a critical factor. Four representative types of cancer, i.e., colon cancer, melanoma, lymphoma, and lung cancer showing sex/gender specificities have been described herein. We underscore that the use of a "gender tailored" approach could provide a better comprehension of the cellular and molecular mechanisms of cancer growth control contributing to the development of novel therapeutic approaches towards an increasingly personalized medicine. The interplay between cancer cells and the tumor microenvironment (TME) has a fundamental role in tumor progression and response to therapy. The plethora of components constituting the TME, such as stroma, fibroblasts, endothelial and immune cells, as well as macromolecules, e.g., hormones and cytokines, and epigenetic factors, such as microRNAs, can modulate the survival or death of cancer cells. Actually, the TME can stimulate the genetically regulated programs that the cell puts in place under stress: apoptosis or, of interest here, autophagy. However, the implication of autophagy in tumor growth appears still undefined. Autophagy mainly represents a cyto-protective mechanism that allows cell survival but, in certain circumstances, also leads to the blocking of cell cycle progression, possibly leading to cell death. Since significant sex/gender differences in the incidence, progression and response to cancer therapy have been widely described in the literature, in this review, we analyzed the roles played by key components of the TME, e.g., estrogen and microRNAs, on autophagy regulation from a sex/gender-based perspective. We focused our attention on four paradigmatic and different forms of cancers—colon cancer, melanoma, lymphoma, and lung cancer—concluding that sex-specific differences may exert a significant impact on TME/cancer interaction and, thus, tumor growth. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. Synergy Between Vitamin D and Sex Hormones in Respiratory Functionality of Patients Affected by COVID-19.
- Author
-
Peruzzu, Daniela, Pagano, Maria Teresa, Pierdominici, Marina, Ruggieri, Anna, Antinori, Andrea, D'Offizi, Gianpiero, Petrosillo, Nicola, Palmieri, Fabrizio, Piselli, Pierluca, Boumis, Evangelo, Notari, Stefania, Nicastri, Emanuele, Agrati, Chiara, Ippolito, Giuseppe, Gagliardi, Maria Cristina, Capobianchi, Maria Rosaria, and Ortona, Elena
- Subjects
SEX hormones ,VITAMIN D ,COVID-19 ,OLDER women ,OLDER men ,AGE differences ,OLDER patients ,WOMEN patients - Abstract
The outcome of COVID-19 appears to be influenced by vitamin D status of population. Although epidemiological data indicate that COVID-19 produces more severe symptoms and higher mortality in elderly in comparison to young patients and in men in comparison to women to date sex and age differences in vitamin D status in infected patients have not been evaluated yet. In this study we evaluated the levels of circulating 25(OH)D in patients hospitalized for COVID-19 divided accordingly to their sex and age. We also correlated 25(OH)D levels with patient's respiratory status (i.e., PaO2/FiO2 ratio) and with sex hormones plasma levels to analyze the potential relationship of these parameters. We found no significant differences in plasma levels of 25(OH)D between pre- and post-menopausal female patients and age matched male patients. Interestingly, the 25(OH)D plasma levels positively correlated to PaO2/FiO2 ratio only in young patients, regardless of their sex. We also found a significantly positive correlation between 17β-estradiol and 25(OH)D in elderly women and between testosterone and 25(OH)D in elderly men, supporting the role of sex hormones in maintaining 25(OH)D levels. In conclusion, we suggest that a synergy between vitamin D and sex hormones could contribute to the age-related outcome of COVID-19. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. Examining the training needs and perspectives of Italian general practitioners on transgender and gender diverse healthcare: Insights from a national survey.
- Author
-
Marconi, Matteo, Brogonzoli, Luisa, Ruocco, Angela, Sala, Elisa, D’Arienzo, Sara, Manoli, Martina, Pagano, Maria Teresa, Fisher, Alessandra Daphne, Iardino, Rosaria, Pedale, Rosa, Grattagliano, Ignazio, Cricelli, Claudio, and Pierdominici, Marina
- Published
- 2024
- Full Text
- View/download PDF
11. Autoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast Cancer.
- Author
-
Maselli, Angela, Parlato, Stefania, Puglisi, Rossella, Raggi, Carla, Spada, Massimo, Macchia, Daniele, Pontecorvi, Giada, Iessi, Elisabetta, Pagano, Maria Teresa, Cirulli, Francesca, Gabriele, Lucia, Carè, Alessandra, Vici, Patrizia, Pizzuti, Laura, Barba, Maddalena, Matarrese, Paola, Pierdominici, Marina, and Ortona, Elena
- Subjects
AUTOANTIBODIES ,HORMONE receptor positive breast cancer - Abstract
Tamoxifen resistance is a major hurdle in the treatment of estrogen receptor (ER)-positive breast cancer. The mechanisms of tamoxifen resistance are not fully understood although several underlying molecular events have been suggested. Recently, we identified autoantibodies reacting with membrane-associated ERα (anti-ERα Abs) in sera of breast cancer patients, able to promote tumor growth. Here, we investigated whether anti-ERα Abs purified from sera of ER-positive breast cancer patients could contribute to tamoxifen resistance. Anti-ERα Abs inhibited tamoxifen-mediated effects on cell cycle and proliferation in MCF-7 cells. Moreover, anti-ERα Abs hampered the tamoxifen-mediated reduction of tumor growth in SCID mice xenografted with breast tumor. Notably, simvastatin-mediated disaggregation of lipid rafts, where membrane-associated ERα is embedded, restored tamoxifen sensitivity, preventing anti-ERα Abs effects. In conclusion, detection of serum anti-ERα Abs may help predict tamoxifen resistance and concur to appropriately inform therapeutic decisions concerning hormone therapy in ER-positive breast cancer patients. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
12. Gender-affirming hormone therapy and autoimmunity: new insights from a three-year follow-up study.
- Author
-
Marconi M, Riitano G, Fisher AD, Cocchetti C, Pagano MT, Capozzi A, Longo A, D'Arienzo S, Vignozzi L, Sorice M, Ortona E, and Pierdominici M
- Published
- 2023
- Full Text
- View/download PDF
13. The Natural Estrogen Receptor Beta Agonist Silibinin as a Promising Therapeutic Tool in Diffuse Large B-cell Lymphoma.
- Author
-
Ortona E, Locatelli SL, Pagano MT, Ascione B, Careddu G, Dupuis ML, Marconi M, Carlo-Stella C, Malorni W, Matarrese P, and Pierdominici M
- Subjects
- Animals, Antineoplastic Agents, Phytogenic pharmacology, Apoptosis drug effects, Autophagy drug effects, Cell Line, Cell Line, Tumor, Cell Proliferation drug effects, Doxorubicin toxicity, Humans, Lymphoma, Large B-Cell, Diffuse pathology, Mice, Myocytes, Cardiac drug effects, Silybin pharmacology, Xenograft Model Antitumor Assays, Antineoplastic Agents, Phytogenic therapeutic use, Estrogen Receptor beta agonists, Lymphoma, Large B-Cell, Diffuse drug therapy, Silybin therapeutic use
- Abstract
Background/aim: About 40% of patients with diffuse large cell lymphoma (DLBCL) still have a poor prognosis. Additionally, DLBCL patients treated with doxorubicin are at risk of cardiac failure. Growing evidence suggests an antitumor and cardioprotective activity exerted by estrogen via its binding to estrogen receptor (ER) β. The aim of this study was to evaluate the anticancer activity of the phytoestrogen silibinin, an ERβ selective agonist, on DLBCL growth, and its potential cardioprotective effect., Materials and Methods: DLBCL cell lines SUDHL-8, SUDHL-6, and RIVA were used. The anti-tumor activity of silibinin was also evaluated in vivo in NOD/SCID/IL2Rg-/- (NSG) xenografted mice. AC16 human ventricular cardiomyocytes were used to investigate the cardioprotective effects of silibinin., Results: In vitro silibinin induced apoptosis and autophagy, and blocked tumor cell proliferation, also protecting AC16 cardiomyocytes from doxorubicin-induced toxicity. In vivo silibinin induced cell death and autophagy, and reduced tumor volume., Conclusion: Silibinin represents a promising therapeutic tool., (Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
14. A Role for Estrogen Receptor alpha36 in Cancer Progression.
- Author
-
Pagano MT, Ortona E, and Dupuis ML
- Subjects
- Disease Progression, Humans, Neoplasms drug therapy, Neoplasms etiology, Neoplasms metabolism, Drug Resistance, Neoplasm, Estrogen Receptor alpha metabolism, Neoplasms pathology
- Abstract
Estrogen receptor α (ERα) functions as a ligand dependent transcription factor that directly binds specific estrogen responsive elements, thus regulating the transcription of estrogen sensitive genes. ERα has also been shown to be associated with the plasma membrane (membrane associated ERα, mERα), concentrated in lipid rafts, plasma membrane microdomains with a distinct lipid composition, where it transduces membrane-initiated estrogen-dependent activation of the mitogen-activated protein (MAP) kinase signaling pathway. Two isoforms of ERα have been described: the "traditional" ERα66 (66 kDa) and a lower molecular weight variant: the ERα46 (46 kDa). More recently, a novel ERα variant with a molecular mass of 36 kDa (ERα36) has been discovered. Notably, ERα36 has been found expressed in different human tumor cells, including both ER- positive and ER- negative breast cancer cells. Estrogen signaling at the cell membrane via ERα36 appears as capable of activating multiple pathways of importance for cancer aggressiveness and metastatic potential. The presence of serum autoantibodies reacting with mERα (anti-ERα Abs) in a large percentage of patients with breast cancer has recently been reported by our group. These anti-ERα Abs seem to act as estrogen agonists rapidly triggering MAP kinase pathway activation thus inducing tumor cell proliferation and overcoming cell resistance to anti-estrogen drug tamoxifen. In this review, we describe the involvement of ERα36 in different tumors. We also report the potential pathogenetic activity of anti-ERα Abs and their implication in drug resistance., (Copyright © 2020 Pagano, Ortona and Dupuis.)
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.